BamSEC and AlphaSense Join Forces
Learn More

ABVC BioPharma Inc.

NASDAQ: ABVC    
Share price (12/26/24): $0.56    
Market cap (12/26/24): $7.253 million

Material Contracts Filter

EX-10.1
from 8-K 5 pages November 1, 2024 Re: Inducement Offer to Exercise Outstanding Warrants to Purchase Common Stock
12/34/56
EX-10.2
from 8-K/A 2 pages Amendment Agreement
12/34/56
EX-10.1
from 8-K/A 2 pages Amendment Agreement
12/34/56
EX-10.2
from 8-K/A 2 pages Amendment to the Definitive License Agreement Between Biofirst Corporation and Forseecon Eye Corporation
12/34/56
EX-10.1
from 8-K/A 2 pages Amendment to the Definitive License Agreement Between the Company and Forseecon Eye Corporation
12/34/56
EX-10.2
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.1
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.2
from 8-K 15 pages ABVC Biopharma, Inc. Common Stock Purchase Warrant
12/34/56
EX-10.1
from 8-K 9 pages May 22, 2024 Re: Inducement Offer to Exercise Existing Warrants to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 6 pages Definitive Licensing Agreement [Signature Page]
12/34/56
EX-10.1
from 8-K 6 pages Definitive Licensing Agreement [Signature Page]
12/34/56
EX-10.2
from 8-K 5 pages Definitive Licensing Agreement [Signature Page]
12/34/56
EX-10.1
from 8-K 5 pages Definitive Licensing Agreement [Signature Page]
12/34/56
EX-10.2
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.1
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.2
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.1
from 8-K 5 pages Definitive Licensing Agreement
12/34/56
EX-10.2
from 8-K/A 4 pages Amendment No. 2 to Secured Convertible Promissory Note
12/34/56
EX-10.2
from 8-K/A 4 pages Amendment No. 1 to Secured Convertible Promissory Note
12/34/56
EX-10.41
from S-1/A 14 pages ABVC Biopharma, Inc. Placement Agent Common Stock Purchase Warrant
12/34/56